TABLE 5.
The comparison of gender, implant side, and CI model for NPC and control groups
| Gender | CI_side | CI_model | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | P‐value | Left | Right | P‐value* | Cochlear | AB | Med‐El | P‐value* | |
| NPC | 14 | 11 | P = .815 | 12 | 13 | p = .321 | 13 | 12 | 0 | P = .0.620 |
| Non‐NPC | 37 | 26 | 23 | 40 | 37 | 24 | 1 | |||
| Total | 51 | 37 | 35 | 53 | 50 | 36 | 1 | |||
*
P values are based on Chi‐square test, with P <.05 indicating statistical significance.
Abbreviations: AB, Advance bionics (Calnifornia, USA); CI, cochlear implantation; Cochlear, cochlear limited (Sydney, Australia); Med‐El, Med‐El (Innsbruck, Austria); NPC, nasopharyngeal cancer.